FDA Approves Sedative-Hypnotic Agent LUSEDRA™ Injection
[ 2008/12/15 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200857.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. Kaken Pharmaceutical to Increase Year-en...
Kaken Pharmaceutical Co.,Ltd. 2003/04/24
2. Notification with Respect to Issuance of...
Eisai Co., Ltd. 2008/05/29
3. GlaxoSmithKline and Kaken Pharmaceutical...
Kaken Pharmaceutical Co.,Ltd. 2002/12/16
4. License Agreement for bFGF in Wound Heal...
Kaken Pharmaceutical Co.,Ltd. 2009/11/13
5. Launching of ゛MIROL Ophth. Soln. 0.5%&qu...
Kaken Pharmaceutical Co.,Ltd. 2001/02/21

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. Eisai Submits Application for Aricept® O...
2008/03/14

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us